Technavio's latest market research reveals a bullish projection for the Global Content Delivery Network Market, predicting a skyrocketing CAGR of 26.87% from 2023-2027, mainly fueled by North America's market dominance due to high internet penetration and smartphone usage.

Berachain emerges as a DeFi leader during the recent crypto bull run, securing unicorn status with a staggering $1.5 billion valuation.

Explore BIGO Ads' advanced advertising solutions at GDC 2024 to boost your game's revenue and unlock new user acquisition strategies with cutting-edge AI and analytics.

In a groundbreaking medical stride, Professors Sir David Klenerman and Sir Shankar Balasubramanian have been honored with the 2024 Novo Nordisk Prize for their seminal work in reducing genome sequencing time to a mere hour. Their transformative discoveries promise a new dawn for personalized healthcare and disease management.

Ezoic has launched a pioneering Enterprise program to support enterprise-level creators by offering advanced SEO, audience engagement, and video optimization tools, alongside expert guidance. The program is set to redefine the digital publishing landscape with innovative AI technologies.

Bitmagic has launched an innovative 3D game-creation platform on Steam Early Access, enabling anyone to design games using simple text prompts. This transformative technology offers ease of access and the ability to create animated 3D objects, democratizing game production for creators of all skill levels.

OKX, a prominent Web3 technology firm, has unveiled innovative wallet features including mass account creation and advanced multisending options, significantly simplifying the airdrop participation process for cryptocurrency enthusiasts globally.

In a potential industry-shaping move, Apple is in discussions to integrate Google's cutting-edge Gemini AI engine into its iPhone software, potentially bringing a suite of AI-driven features to the beloved iOS platform.

Selvita S.A. announces a significant strategic expansion into therapeutic antibody discovery, showcasing an ambitious move to enhance their biologic drug discovery and development capabilities. The initiative, indicative of Selvita's commitment to innovation, positions the company as a leader in biologic research and caters to the growing needs of the pharmaceutical industry.

Discover the explosive rise of Digital Surgery Technologies, set to hit $6.07 Bn by 2031, revolutionizing surgical precision and efficiency across the globe.